Phenytoin Sodium

CHEMBL1611 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
274.2 g/mol
LogP
Phase
4

A sodium salt form of phenytoin with the same therapeutic properties. A medication used to prevent and control seizures in epilepsy by stabilizing the electrical activity in the brain.

分子量

274.2500 g/mol

TPSA

47.20 Ų

治疗领域

作用机制

Sodium channel blocker stabilizing inactive state.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Sodium channel blocker stabilizing inactive state.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1N=C([O-])NC1(c1ccccc1)c1ccccc1.[Na+]

InChI

InChI=1S/C15H12N2O2.Na/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12;/h1-10H,(H2,16,17,18,19);/q;+1/p-1

Molecular Formula

C15H11N2NaO2

HBD / HBA

1 / 3

可旋转键数

2

重原子数

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A sodium salt form of phenytoin with the same therapeutic properties. A medication used to prevent and control seizures in epilepsy by stabilizing the electrical activity in the brain.

Sodium channel blocker stabilizing inactive state.

Yes, Phenytoin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1611. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 657302. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.